Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xudong Zhang
Institution:
First Affiliated Hospital of Zhengzhou University
Observed institutions:
BGI Group (China),
Institute of Food Science and Technology,
Chinese Academy of Agricultural Sciences,
First Affiliated Hospital of Zhengzhou University,
Bohai University
ORCID:
0000-0001-8515-8189
Observed ORCIDs:
0000-0001-8515-8189,
0000-0002-1930-5563
OpenAlex ID:
A5092083396
Adaptive Fault-Tolerant Control-Based Real-Time Reachable Set Synthesis of Heterogeneous Nonlinear Singular Multiagent Systems With Uncertain Parameters
2023
·
Liang Zhang
, Xudong Zhang
, et al.
·
IEEE Transactions on Automation Science and Engineering
·
67
Hot air treatment alleviates chilling injury of sweet potato tuberous roots by regulating osmoregulatory substances and inducing antioxidant defense system
2024
·
Jinxiao Cheng
, Xudong Zhang
, et al.
·
Food Chemistry
·
18
Hot water pre-treatment alleviates chilling injury in sweet potato: Synergistic regulatory effects on antioxidant and energy metabolism
2025
·
Xudong Zhang
, Jinxiao Cheng
, et al.
·
Postharvest Biology and Technology
·
8
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)
2024
·
Yue Zhang
, Jingwen Chu
, et al.
·
International Journal of Oncology
·
7
PDF
Real-Time Reachable Set Synthesis of Takagi–Sugeno Fuzzy Uncertain Singular Systems Based on Adaptive Event-Triggered Scheme
2023
·
Xudong Zhang
, Liang Zhang
, et al.
·
International Journal of Fuzzy Systems
·
4
Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T‐cell lymphoma
2023
·
Ziyuan Shen
, Xicheng Chen
, et al.
·
Cancer Medicine
·
4
PDF
Longitudinal ctDNA tracking by low-pass whole-genome sequencing predicts CAR-T outcomes in B-cell lymphomas
2026
·
Sijun Zhang
, Honghan Qiao
, et al.
·
iScience
·
2
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
2024
·
Ziyuan Shen
, Xudong Zhang
, et al.
·
Future Oncology
·
2
PDF
A first‐line regimen combining Bruton's tyrosine kinase and programmed cell death protein‐1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma
2026
·
Wanyue Zhao
, Ling Li
, et al.
·
Cancer
·
1
APOC1 inhibit NKTCL doxorubicin sensitivity by promoting mitophagy
2025
·
Sa Xiao
, Jing Kuang
, et al.
·
IUBMB Life
·
1
Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis
2023
·
Fenghua Gao
, Jing Liu
, et al.
·
Blood
·
1
531 Phase I study to assess the safety, immunogenicity, and preliminary antitumor activity of the EBV mRNA vaccine (WGc-043 injection) in patients with R/R lymphoma
2026
·
He Li
, Shu Cheng
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
AI-guided discovery of the IRF4-PAICS-LDHA axis as a multitarget hub linking tumor metabolism to CD8+ T cell exhaustion in DLBCL
2026
·
Zeyuan Wang
, Liye wang
, et al.
·
npj Precision Oncology
Plasma untargeted metabolomics reveals the metabolic landscape of NKTCL and aids in liquid biopsy for disease detection
2025
·
Siyu Qian
, Yue Zhang
, et al.
·
European journal of medical research
Correction: Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study
2025
·
Wenhua Wang
, Bingyi Wang
, et al.
·
Frontiers in Immunology
PDF
The association between maternal amino acids and vitamins status during early pregnancy and preterm birth
2024
·
Shurong Sun
, Dan Cheng
, et al.
·
Research Square
PDF
328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies
2023
·
Xin-Feng Chen
, Dan Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
S234: Updated Clinical Results of First-in-human Study of Cd19/bcma Dual-targeting Fast Car-t Gc012f for Patients With Relapsed/refractory B-cell Non-hodgkin’s Lymphoma
2023
·
Xinfeng Chen
, Yu Ping
, et al.
·
HemaSphere
Updated clinical results of first-in-human study of CD19/BCMA dual-targeting fast CAR-T GC012F for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma.
2023
·
Xinfeng Chen
, Ping Yu
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
19
Citation count:
115
H-index:
4
I10-index:
2
Year
Topic
Type